.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

SWASTHFIT COMPLETE PACKAGE

LIVER & KIDNEY PANEL, SERUM

(Spectrophotometry, Indirect ISE)

Creatinine 0.70 mg/dL 0.67 - 1.17

GFR Estimated 110 mL/min/1.73m2 >59

GFR Category G1

Urea 22.80 mg/dL 17.00 - 43.00

Urea Nitrogen Blood 10.65 mg/dL 6.00 - 20.00

BUN/Creatinine Ratio 15

Uric Acid 4.60 mg/dL 3.50 - 7.20

AST (SGOT) 32.7 U/L <50

ALT (SGPT) 40.5 U/L <50

GGTP 23.0 U/L <55

Alkaline Phosphatase (ALP) 68.40 U/L 30 - 120

Bilirubin Total 0.70 mg/dL 0.30 - 1.20

Bilirubin Direct 0.15 mg/dL <0.20

Bilirubin Indirect 0.55 mg/dL <1.10

Total Protein 7.00 g/dL 6.40 - 8.30

Albumin 4.51 g/dL 3.50 - 5.20

A : G Ratio 1.81 0.90 - 2.00

Globulin(Calculated) 2.49 gm/dL 2.0 - 3.5

Calcium, Total 9.97 mg/dL 8.80 - 10.60

*178811265* Page 1 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Phosphorus 2.81 mg/dL 2.40 - 4.40

Sodium 139.00 mEq/L 136.00 - 146.00

Potassium 3.60 mEq/L 3.50 - 5.10

Chloride 102.40 mEq/L 101.00 - 109.00

*178811265* Page 2 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

LIPID SCREEN, SERUM

(CHO-POD)

Cholesterol, Total 116.30 mg/dL <200.00

Triglycerides 230.20 mg/dL <150.00

HDL Cholesterol 32.20 mg/dL >40.00

LDL Cholesterol, Calculated 38.06 mg/dL <100.00

VLDL Cholesterol,Calculated 46.04 mg/dL <30.00

Non-HDL Cholesterol 84 mg/dL <130

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered
among patients with moderate risk for ASCVD for risk refinement.

Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category B | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------|--------------------|
| Low | <100 | <130 | ≥130* | ≥160* |
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

*178811265* Page 3 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA

(Hexokinase)

Glucose Fasting 197.00 mg/dL 70.00 - 100.00

VITAMIN B12; CYANOCOBALAMIN, SERUM

(ECLIA)

Vitamin B12; Cyanocobalamin 597.00 pg/mL 211.00 - 946.00

Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific

3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients

4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity

VITAMIN D, 25 - HYDROXY, SERUM

(ECLIA)

Vitamin D, 25 Hydroxy 82.50 nmol/L 75.00 - 250.00

Interpretation
--------------------------------------------------------------------------------------------
| LEVEL | REFERENCE RANGE IN nmol/L| COMMENTS |
|---------------|--------------------------|-------------------------------------------------|
| Deficient | < 50 | High risk for developing bone disease |
|---------------|--------------------------|-------------------------------------------------|
| Insufficient | 50-74 | Vitamin D concentration which normalizes |
| | | Parathyroid hormone concentration |
|---------------|--------------------------|-------------------------------------------------|
| Sufficient | 75-250 | Optimal concentration for maximal health benefit|
|---------------|--------------------------|-------------------------------------------------|
| Potential | >250 | High risk for toxic effects |
| intoxication | | |
--------------------------------------------------------------------------------------------

*178811265* Page 4 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

THYROID PROFILE,TOTAL, SERUM

(ECLIA)

T3, Total 0.99 ng/mL 0.80 - 2.00

T4, Total 8.39 µg/dL 5.10 - 14.10

TSH 3.30 µIU/mL 0.27 - 4.20

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals

AMYLASE, SERUM
(IFCC)

Amylase 57.70 U/L 28.00 - 100.00

IRON STUDIES, SERUM

(Spectrophotometry, TPTZ, NITROSO - PSAP)

Iron 99.30 µg/dL 65.00 - 175.00

*178811265* Page 5 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Total Iron Binding Capacity (TIBC) 458.50 µg/dL 250.00 - 425.00

Transferrin Saturation 21.66 % 20.00 - 50.00

*178811265* Page 6 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 Plot No. 60, Sector 12 B, Dwarka-New
CENTRAL MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP Certified)

HbA1c 7.2 % 4 - 5.6

Estimated average glucose (eAG) 160 mg/dL

Interpretation
HbA1c result is suggestive of Diabetes/ Higher than glycemic goal in a known Diabetic patient.

Please note, Glycemic goal should be individualized based on duration of diabetes, age/life expectancy,
comorbid conditions, known CVD or advanced microvascular complications, hypoglycaemia unawareness,
and individual patient considerations

Result Rechecked,
Please Correlate Clinically.

Interpretation as per American Diabetes Association (ADA) Guidelines

------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*178811265* Page 7 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

CARDIO C-REACTIVE PROTEIN (hsCRP), SERUM 1.18 mg/L <1.00

(Immunoturbidimetry)
Interpretation
--------------------------------------------------------------
| CARDIO CRP IN mg/L | CARDIOVASCULAR RISK |
|-----------------------|--------------------------------------|
| <1 | Low |
|-----------------------|--------------------------------------|
| 1-3 | Average |
|-----------------------|--------------------------------------|
| 3-10 | High |
|-----------------------|--------------------------------------|
| >10 | Persistent elevation may represent |
| | Non cardiovascular inflammation |
--------------------------------------------------------------

APOLIPOPROTEINS A1 & B, SERUM

(Immunoturbidimetry)

Apolipoprotein (Apo A1) 108 mg/dL 105.00 - 175.00

Apolipoprotein (Apo B) 71 mg/dL 60.00 - 140.00

Apo B / Apo A1 Ratio 0.66 0.35 - 0.98

As per recommendations of National Cholesterol Education Program (NCEP) the clinical

significance of results is as follows:

Apolipoprotein B
-----------------------------------------------------------------------------
| RESULT IN mg/dL | REMARKS |
|--------------------------|-------------------------------------------------|
| <23 |Abetalipoproteinemia/Hypobetalipoproteinemia |
|--------------------------|-------------------------------------------------|
| 23-45 |Hypobetalipoproteinemia |
|--------------------------|-------------------------------------------------|
| 46-135 |Normal |
| -------------------------|-------------------------------------------------|
| >135 |Hyperapobetalipoproteinemia/Increased CAD risk |
--------------------------|-------------------------------------------------
Apo B to A1 Ratio
-------------------------------
| RATIO | REMARKS |
|------------|------------------|
| 0.35-0.98 | Desirable |
|------------|------------------|
| >0.98 |Increased CAD risk|
-------------------------------

*178811265* Page 8 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E.
(Automated Strip test, Chemical, Light microscopy)

Gross Examination

Colour Pale Yellow Pale yellow

Specific Gravity 1.015 1.001 - 1.030

pH 6.5 5.0 - 8.0

Proteins Negative Negative

Glucose Present 2+(0.5 g/dL) Negative

Ketones Negative Negative

Bilirubin Negative Negative

Urobilinogen Normal Normal

Blood Negative Negative

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

*178811265*
Page 9 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Microscopy

R.B.C. Negative 0-2 RBC/hpf

Pus Cells 2-3 WBC/HPF 0-5 WBC / hpf

Epithelial Cells 0-1 Epi Cells/hpf 0-5 Epi cells/hpf

Casts None seen None seen/Lpf

Crystals None seen None seen

Others None seen None seen

Result Rechecked,
Please Correlate Clinically.

Result Rechecked,
Please Correlate Clinically.

*178811265*
Page 10 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

HEMOGRAM
(SLS Method, Sheath Flow DC Detection Method, Fluorescent Flow Cytometry, Calculated & Capillary Photometry)
Hemoglobin 13.30 g/dL 13.00 - 17.00

Packed Cell Volume (PCV) 42.80 % 40.00 - 50.00

RBC Count 4.66 mill/mm3 4.50 - 5.50

MCV 91.80 fL 83.00 - 101.00

Mentzer Index 19.7

MCH 28.50 pg 27.00 - 32.00

MCHC 31.10 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 14.60 % 11.60 - 14.00

Total Leukocyte Count (TLC) 5.59 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Segmented Neutrophils 64.60 % 40.00 - 80.00

Lymphocytes 22.40 % 20.00 - 40.00

Monocytes 10.20 % 2.00 - 10.00

Eosinophils 2.30 % 1.00 - 6.00

Basophils 0.50 % <2.00

Absolute Leucocyte Count

Neutrophils 3.61 thou/mm3 2.00 - 7.00

Lymphocytes 1.25 thou/mm3 1.00 - 3.00

Monocytes 0.57 thou/mm3 0.20 - 1.00

Eosinophils 0.13 thou/mm3 0.02 - 0.50

*178811265* Page 11 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

Basophils 0.03 thou/mm3 0.02 - 0.10

Platelet Count 169 thou/mm3 150.00 - 410.00

Mean Platelet Volume 13.1 fL 6.5 - 12.0

E.S.R. 9 mm/hr 0.00 - 20.00

Comment
In anaemic conditions Mentzer index is used to differentiate Iron Deficiency Anaemia from Beta- Thalassemia
trait. If Mentzer Index value is >13, there is probability of Iron Deficiency Anaemia. A value <13 indicates likelihood
of Beta- Thalassemia trait and Hb HPLC is advised to rule out the Thalassemia trait.

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

*178811265* Page 12 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, POST PRANDIAL (PP), 2 HOURS, 200.60 mg/dL 70.00 - 140.00

PLASMA
(Hexokinase)

Result Rechecked,
Please Correlate Clinically.

Note
1. The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL and/or a random / 2
hr post glucose value of > or = 200 mg/dL on at least 2 occasions

2. Very low glucose levels cause severe CNS dysfunction

3. Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis & is considered
critical

Interpretation
---------------------------------------------------------------------------
| Status | Fasting plasma glucose | PP plasma glucose |
| | in mg/dL | in mg/dL |
|---------------------------|------------------------|----------------------|
| Normal | 70-100 | 70-140 |
|---------------------------|------------------------|----------------------|
| Impaired fasting glucose | 101-125 | 70-140 |
|---------------------------|------------------------|----------------------|
| Impaired glucose tolerance| 70-100 | 141-199 |
|---------------------------|------------------------|----------------------|
| Pre-Diabetes | 101-125 | 141-199 |
|---------------------------|------------------------|----------------------|
| Diabetes mellitus | >126 | >200 |
---------------------------------------------------------------------------

Comments
Conditions which can lead to lower postprandial glucose levels as compared to fasting glucose are excessive
insulin release, rapid gastric emptying & brisk glucose absorption.

Probable causes:

· Early Type II Diabetes / Glucose intolerance

· Drugs like Salicylates, Beta blockers, Pentamidine etc.
· Alcohol
· Dietary - Intake of excessive carbohydrates and foods with high glycemic index

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*178811265*
Page 13 of 14
.

Name : Mr. S K SINGH

Lab No. : 178811265 Age : 53 Years
Ref By : SELF Gender : Male
Collected : 20/10/2024 8:18:00AM Reported : 20/10/2024 3:56:00PM
A/c Status : P Report Status : Final
Collected at : PSC-DWARKA 6 Processed at : DWARKA -2
54A, SECTOR 6, POCKET 2, SECTOR 6 CENTRAL Plot No. 60, Sector 12 B, Dwarka-New
MARKET DWARKA Delhi-110075
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

· Exercise in between samples
· Family history of Diabetes
· Idiopathic
· Partial/ Total Gastrectomy

Dr. Arohi Gupta

MBBS,MD Pathology
Chief of Laboratory
Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHJFJGNLOHBBNPCBILLJCECCJLCIKPKNKEDFEFAPPAHEEEHA
BNFFFNBPAPBOIOMGFGEHJOAPAOAHFHAKBONOBCJKBLELNOJGMPBNFFFNB
GMDACAFLNPNOGHGNHFIAAJHFJGFEHEDDJKPHENFLMKLMOEFLBKHDEHANP
DJLMEOFNBKMIELEJLLPELEPFANPKBLAFJIFFOAPAKKNJPDNLIJNBKEMEL
LDBCJLFIOBBFDIACMDPGMHBDLENLKDKHKKMFAKMIPLKGKPNGKFFFOOMNH
OECBBEFDPECAMIHKIMFLIIPBADHFOFAINDFCBKDKALIKOMNALNEJOGECL
LFIMIJFJILOGBFLIEOIKGFEHIHAFJBALONOPBLMKOJCHKNFMIJNFIDILD
BNFNAMFNBJOFFECMAANHDAOILKBMFMBDOFCCAMNNIJKDKPNGBNFMBHILL
NKGFCFFFDNDGFEIDENMIHNJKHOMFEKFBJFFKALOFOEBIOCNKDJPHNEKLJ
PPNOMFFCELMJJDCKMEEOIDJJADFKPNJHKEPHELFLNKCKIGEOCBOKHICIL
AGIKNMFLGKKKNODMPEAAPJEEINMPNANBJNFEBFOFPNDMKPFKEPCIGKIMG
IKICGJFMMLDPIJKMHPCFAODEIEOPPFOEAONPBLNOOLJAIANIPKONHDICL
MNNNNNEHKEAOFKMAGCFLHLCHJBAHFHAHNKPFCMNLMKJIPFNOAHFHAHIKL
APBBBPAPBKCAEBFBMPAKCAEFAHECHHCAONFEOKOGOLMHNLNFEDFCCBKHH
HHHHHHHPHHPPHPPHPPPPPHPHHHPPPPPPPPPHHHHPPHHHPHPHHHHHPHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost for
derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe Courts/Forum
at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid for medico legal
purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner /Doctor.ŸThe report does
not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*178811265*
Page 14 of 14